Klaritos
Klaritos is a biotech company based in Menlo Park, CA that aims to integrate precision medicine protocols with marketed biotech drugs, offering therapeutic, cost, and time advantages to payers and patients. Their transformative platform operates as a patient-centric, virtual clinical trial, treating up to 1 million patients per disease and conducting real-world evidence trials, while avoiding conflicts from pharma companies and payers.
With a focus on disease segments such as Alzheimer's, autoimmune and inflammatory disorders, select cancers, and rare diseases, Klaritos provides proprietary solutions including ultra-large treatment trial protocols, disease-specific big data warehouse protocols, and a payer-sponsored model that disrupts the traditional big pharma development model, eliminating the need for middlemen and enabling accelerated development and commercialization.
Generated from the website
